New Key Statistics Module, Z-Score and F-Score
NAS:EVAX Key Ratios
| Market Cap $ M | 17.40 |
| Enterprise Value $ M | 19.89 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 3.02 |
| Price/Book | 13.45 |
| Price/Sales | 47.27 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -4.50 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -21.60 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -1.31 |
| EV-to-EBITDA | -1.31 |
| PEG | -- |
| Shares Outstanding M | 5.58 |
| Net Margin (%) | -5,469.42 |
| Operating Margin % | -6,871.58 |
| Pre-tax Margin (%) | -5,752.88 |
| Quick Ratio | 2.80 |
| Current Ratio | 2.80 |
| ROA % (ttm) | -95.67 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -223.07 |
| Dividend Yield % | -- |
| Altman Z-Score | -12.38 |
EVAX Number of Guru Trades
EVAX Volume of Guru Trades
Gurus Latest Trades with NAS:EVAX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:EVAX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Evaxion Biotech AS Insider Transactions
No Available Data
News about NAS:EVAX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers